Prostatic Artery Embolization for Benign Prostatic Hyperplasia

Guideline Recommendations

• The American Urological Association recommends that Prostatic Artery Embolization (PAE) should not be used outside clinical trials for the treatment of Lower Urinary Tract Symptoms (LUTS)/Benign Prostatic Hyperplasia (BPH) 1
• PAE is not included in the standard treatment options for BPH in established guidelines, with traditional surgical options like Transurethral Resection of the Prostate (TURP) remaining the benchmark for surgical therapies due to published evidence from randomized clinical trials with long-term follow-up 2, 3, 4

Treatment Options

• The American Urological Association suggests medical therapy with alpha-blockers and 5-alpha reductase inhibitors as an established option for patients seeking treatment for BPH 5
• Standard surgical interventions like TURP, laser enucleation (HoLEP, ThuLEP) are recommended as established treatment options for BPH 7, 1